India’s commerce department has cut off exports of anti-malaria drug and COVID-19 treatment hopeful hydroxychloroquine. Previously banned by the FDA after findings that the drug was produced in plants that faked safety data, the ban was lifted due to the high demand for the drug. These trade restrictions will cause an interference in the drug supply and could have serious consequences, especially for those already taking the medication for immune conditions. Yourway has global depots located around the world and is able to move shipments freely to ensure all clinical trial materials are delivered on-time to patients that need them most.
Back to Index
6681 Snowdrift Road
Toll Free:
Fax:
Email:
